SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Catalytica Energy Systems, Inc. (CESI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Erik T who wrote (1450)1/25/2000 2:29:00 AM
From: Dan B.  Read Replies (1) of 1514
 
Erik,

I just read your previous posts and I can only mention what a fantastic job you've done.

Your anti-fuel cell arguments are compelling, to say the least.

CTAL's Xonon results and prospects appear excellent, and the agreements with GE and the rest are major confirmation of that notion. Revenues from Xonon in 2000 wouldn't surprise me a bit. CTAL has delivered, as has been mentioned a few times on the thread, responsible and conservative estimates that have only been exceeded by results. I am aware of some who thought the original GE announcement would carry CTAL beyond the 20's for good. The Pharm. side has blossomed and turned profitable since then, and all indications are that the same is soon going to occur on the combustion side of the business. I suspect the current price of CTAL is a bargain. As you've hinted, the Pharm. side alone could support a greater stock price, being set to generate significantly greater profits in coming years.

Thanks for the effort,

Dan B
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News